1 / 5

Cancer immunotherapy Market Revolutionary Trends in Industry Statistics by 2020-2027

cancer immunotherapy market<br>

swati15
Télécharger la présentation

Cancer immunotherapy Market Revolutionary Trends in Industry Statistics by 2020-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Immunotherapy market To Reach USD 153.03 Billion By 2027 www.reportsanddata.com

  2. Market Summary The global cancer immunotherapy market is forecasted to reach USD 153.03 billion in 2027, according to a new report by Reports and Data. The global cancer immunotherapy market is growing at a substantial pace owing to the growing acceptance and inclination of the patients towards the newly invented advanced treatments over the conventional ones. In order to substantialize the severe and chronic diseases like cancer, every year, the cancer research centers invest a handful of the amount in their R&D, which fuels up the market growth by a large margin. The key factors responsible to drive the growth of cancer immunotherapy market include the technological advancements in treatment therapies, rise in incidence of cancer, increasing number of R&D for the treatment of cancer, and improving effectiveness of cancer immunotherapy for the treatment of a wide range of diseases such as lung cancer, breast cancer, skin cancer, and others. Besides, the rise in healthcare expenditure and healthcare insurance are expected to fuel the market growth during the analysis period. www.reportsanddata.com Read More: https://www.reportsanddata.com/report-detail/cancer-immunotherapy-market

  3. Market Summary Further key findings from the report suggest • The North America cancer immunotherapy market is anticipated to dominate the in the global market. The major driving factors for the growth of this market are rise in the adoption rate of immunotherapy over the conventional treatments due to lesser side effects and more survival efficiency and the diminishing lifestyle and increase in the rate of cancer affected patients. • The monoclonal antibodies are expected to have the largest market share among the other segments. This is attributed to the fact that monoclonal antibodies have the largest class of drugs than other sectors of the cancer immunotherapy. The major market driver of the monoclonal antibodies market is the increasing prevalence of cancer in the forecast period. • In the year 2018, Johns Hopkins researchers had invented a new class of drugs for cancer immunotherapy that are more effective at harnessing the power of the immune. The immune system is naturally able to detect and eliminate tumor cells. www.reportsanddata.com Key participants include Bristol-Myers Squibb, Novartis International Ag, Celgene Corporation, Amgen Inc., Amgen Inc., Merck & Co. Inc., Janssen Global Services, LLC, Seattle Genetics Inc, Printegra, Gristone Oncology, Inc, and Pfizer Inc. among others. •

  4. Market Summary For the purpose of this report, Reports and Data have segmented into the global Cancer immunotherapy market on the basis of technology, application, end use, and region: • Technology Outlook (Revenue, USD Billion; 2017-2027) Monoclonal Antibodies Vaccines Checkpoint Inhibitors Cell Therapies Immune System Modulators Adoptive Cell Transfer Cytokines Others • • • • • • • • • www.reportsanddata.com Application Outlook (Revenue, USD Billion; 2017-2027) Head & Neck Cancer Blood Cancers Liver Cancer Lung Cancer • • • • •

  5. About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. Contact US Contact US We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. www.reportsanddata.com John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related